These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
64. Can pancreatic duct-derived progenitors be a source of islet regeneration? Xia B; Zhan XR; Yi R; Yang B Biochem Biophys Res Commun; 2009 Jun; 383(4):383-5. PubMed ID: 19324022 [TBL] [Abstract][Full Text] [Related]
65. Analysis of human and mouse reprogramming of somatic cells to induced pluripotent stem cells. What is in the plate? Boué S; Paramonov I; Barrero MJ; Izpisúa Belmonte JC PLoS One; 2010 Sep; 5(9):. PubMed ID: 20862250 [TBL] [Abstract][Full Text] [Related]
66. Production of beta-cells from human embryonic stem cells. Baetge EE Diabetes Obes Metab; 2008 Nov; 10 Suppl 4():186-94. PubMed ID: 18834446 [TBL] [Abstract][Full Text] [Related]
67. Cellular sources of new pancreatic beta cells and therapeutic implications for regenerative medicine. Halban PA Nat Cell Biol; 2004 Nov; 6(11):1021-5. PubMed ID: 15516994 [TBL] [Abstract][Full Text] [Related]
68. Acquisition of Dynamic Function in Human Stem Cell-Derived β Cells. Velazco-Cruz L; Song J; Maxwell KG; Goedegebuure MM; Augsornworawat P; Hogrebe NJ; Millman JR Stem Cell Reports; 2019 Feb; 12(2):351-365. PubMed ID: 30661993 [TBL] [Abstract][Full Text] [Related]
69. Development of Islet Organoids from H9 Human Embryonic Stem Cells in Biomimetic 3D Scaffolds. Wang W; Jin S; Ye K Stem Cells Dev; 2017 Mar; 26(6):394-404. PubMed ID: 27960594 [TBL] [Abstract][Full Text] [Related]
70. Diabetes mellitus: a potential target for stem cell therapy. Burns CJ; Persaud SJ; Jones PM Curr Stem Cell Res Ther; 2006 May; 1(2):255-66. PubMed ID: 18220871 [TBL] [Abstract][Full Text] [Related]
72. Human Induced Pluripotent Stem Cells in the Curative Treatment of Diabetes and Potential Impediments Ahead. Dadheech N; James Shapiro AM Adv Exp Med Biol; 2019; 1144():25-35. PubMed ID: 30569414 [TBL] [Abstract][Full Text] [Related]
73. In vitro-generation of surrogate islets from adult stem cells. Peck AB; Ramiya V Transpl Immunol; 2004 Apr; 12(3-4):259-72. PubMed ID: 15157920 [TBL] [Abstract][Full Text] [Related]
74. In vitro models of pancreatic differentiation using embryonic stem or induced pluripotent stem cells. Higuchi Y; Shiraki N; Kume S Congenit Anom (Kyoto); 2011 Mar; 51(1):21-5. PubMed ID: 21129040 [TBL] [Abstract][Full Text] [Related]
75. Understanding pancreas development for β-cell repair and replacement therapies. Raducanu A; Lickert H Curr Diab Rep; 2012 Oct; 12(5):481-9. PubMed ID: 22782495 [TBL] [Abstract][Full Text] [Related]
76. [Stem cell therapy for diabetes mellitus: progress, prospects and challenges]. Urbán SV; Kiss J; Vas V; Kovács J; Uher F Orv Hetil; 2006 Apr; 147(17):791-7. PubMed ID: 16780187 [TBL] [Abstract][Full Text] [Related]
77. Cell aggregation optimizes the differentiation of human ESCs and iPSCs into pancreatic bud-like progenitor cells. Toyoda T; Mae S; Tanaka H; Kondo Y; Funato M; Hosokawa Y; Sudo T; Kawaguchi Y; Osafune K Stem Cell Res; 2015 Mar; 14(2):185-97. PubMed ID: 25665923 [TBL] [Abstract][Full Text] [Related]
78. Resveratrol ameliorates the maturation process of β-cell-like cells obtained from an optimized differentiation protocol of human embryonic stem cells. Pezzolla D; López-Beas J; Lachaud CC; Domínguez-Rodríguez A; Smani T; Hmadcha A; Soria B PLoS One; 2015; 10(3):e0119904. PubMed ID: 25774684 [TBL] [Abstract][Full Text] [Related]
79. Demethylation of induced pluripotent stem cells from type 1 diabetic patients enhances differentiation into functional pancreatic β cells. Manzar GS; Kim EM; Zavazava N J Biol Chem; 2017 Aug; 292(34):14066-14079. PubMed ID: 28360105 [TBL] [Abstract][Full Text] [Related]
80. I. How can you choose the fate of iPSCs and stem cells, Regeneration or Carcinogenesis? A hypothetical insight.: II. Modelling human beta cell development with pluripotent stem cells. Seno M; Nostro MC J Stem Cells Regen Med; 2020; 16(2):90-91. PubMed ID: 33414585 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]